pathway_name,pathway_source,num_overlapping_genes,overlapping_genes,num_all_pathway_genes,P_genes,Q_genes,,
Abortive elongation of HIV-1 transcript in the absence of Tat,Reactome,2,SPT5H_HUMAN;NCBP1_HUMAN,23 (23),0.00276,1,0.000714286,70
carnosine biosynthesis,HumanCyc,1,CRNS1_HUMAN,1 (1),0.00342,1,,
homocarnosine biosynthesis,HumanCyc,1,CRNS1_HUMAN,1 (1),0.00342,1,,
mRNA Capping,Reactome,2,SPT5H_HUMAN;NCBP1_HUMAN,29 (29),0.00437,1,,
Formation of the HIV-1 Early Elongation Complex,Reactome,2,SPT5H_HUMAN;NCBP1_HUMAN,33 (33),0.00563,1,,
Formation of the Early Elongation Complex,Reactome,2,SPT5H_HUMAN;NCBP1_HUMAN,33 (33),0.00563,1,,
UDP-D-xylose and UDP-D-glucuronate biosynthesis,HumanCyc,1,UGDH_HUMAN,2 (2),0.00682,1,,
signal transduction through il1r,BioCarta,2,IRAK2_HUMAN;PEBP1_HUMAN,37 (37),0.00704,1,,
Formation of the active cofactor_ UDP-glucuronate,Reactome,1,UGDH_HUMAN,3 (3),0.0102,1,,
methylglyoxal degradation I,HumanCyc,1,GLO2_HUMAN,3 (3),0.0102,1,,
Pyruvaldehyde Degradation,SMPDB,1,GLO2_HUMAN,3 (3),0.0102,1,,
Formation of HIV-1 elongation complex containing HIV-1 Tat,Reactome,2,SPT5H_HUMAN;NCBP1_HUMAN,49 (50),0.0121,1,,
Tat-mediated elongation of the HIV-1 transcript,Reactome,2,SPT5H_HUMAN;NCBP1_HUMAN,49 (50),0.0121,1,,
HIV Transcription Elongation,Reactome,2,SPT5H_HUMAN;NCBP1_HUMAN,49 (50),0.0121,1,,
Formation of HIV elongation complex in the absence of HIV Tat,Reactome,2,SPT5H_HUMAN;NCBP1_HUMAN,51 (52),0.0131,1,,
Neurotransmitter release cycle,Reactome,2,SYN3_HUMAN;S22A1_HUMAN,51 (51),0.0131,1,,
Regulation of Apoptosis,Reactome,1,OPA1_HUMAN,4 (4),0.0136,1,,
NGF processing,Reactome,1,PCSK5_HUMAN,4 (4),0.0136,1,,
Expression and Processing of Neurotrophins,Reactome,1,PCSK5_HUMAN,4 (4),0.0136,1,,
Calcium Regulation in the Cardiac Cell,Wikipathways,3,GBG3_HUMAN;ADA1D_HUMAN;RYR3_HUMAN,149 (149),0.0142,1,,
Abacavir transmembrane transport,Reactome,1,S22A1_HUMAN,5 (5),0.017,1,,
Succinyl CoA: 3-ketoacid CoA transferase deficiency,SMPDB,1,HMCS2_HUMAN,5 (5),0.017,1,,
Ketone Body Metabolism,SMPDB,1,HMCS2_HUMAN,5 (5),0.017,1,,
Synthesis and Degradation of Ketone Bodies,Wikipathways,1,HMCS2_HUMAN,5 (5),0.017,1,,
RNA Polymerase II Transcription Elongation,Reactome,2,SPT5H_HUMAN;NCBP1_HUMAN,64 (65),0.0201,1,,
Formation of RNA Pol II elongation complex ,Reactome,2,SPT5H_HUMAN;NCBP1_HUMAN,64 (65),0.0201,1,,
Synthesis of Lipoxins (LX),Reactome,1,PTGR1_HUMAN,6 (6),0.0203,1,,
2_-deoxy-α-D-ribose 1-phosphate degradation,HumanCyc,1,DEOC_HUMAN,6 (6),0.0203,1,,
IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation,Reactome,1,IRAK2_HUMAN,6 (6),0.0203,1,,
IRAK2 mediated activation of TAK1 complex,Reactome,1,IRAK2_HUMAN,6 (6),0.0203,1,,
Tramadol Pharmacokinetics,PharmGKB,1,S22A1_HUMAN,7 (7),0.0237,1,,
Metformin Pathway_ Pharmacokinetics,PharmGKB,1,S22A1_HUMAN,7 (7),0.0237,1,,
Tramadol Metabolism Pathway,SMPDB,1,S22A1_HUMAN,7 (7),0.0237,1,,
Synthesis of Ketone Bodies,Reactome,1,HMCS2_HUMAN,8 (8),0.027,1,,
Histidine catabolism,Reactome,1,CRNS1_HUMAN,8 (8),0.027,1,,
Galactosemia III,SMPDB,1,UGDH_HUMAN,8 (8),0.027,1,,
Galactosemia II (GALK),SMPDB,1,UGDH_HUMAN,8 (8),0.027,1,,
Nucleotide Sugars Metabolism,SMPDB,1,UGDH_HUMAN,8 (8),0.027,1,,
Butyrate Metabolism,SMPDB,1,HMCS2_HUMAN,8 (8),0.027,1,,
ketogenesis,HumanCyc,1,HMCS2_HUMAN,8 (8),0.027,1,,
Transcription of the HIV genome,Reactome,2,SPT5H_HUMAN;NCBP1_HUMAN,76 (77),0.0277,1,,
Adrenoceptors,Reactome,1,ADA1D_HUMAN,9 (9),0.0303,1,,
sphingosine and sphingosine-1-phosphate metabolism,HumanCyc,1,PTGR1_HUMAN,9 (9),0.0303,1,,
SLBP independent Processing of Histone Pre-mRNAs,Reactome,1,NCBP1_HUMAN,10 (10),0.0337,1,,
Synthesis and degradation of ketone bodies - Homo sapiens (human),KEGG,1,HMCS2_HUMAN,10 (10),0.0337,1,,
Abacavir transport and metabolism,Reactome,1,S22A1_HUMAN,10 (10),0.0337,1,,
Ketone body metabolism,Reactome,1,HMCS2_HUMAN,10 (10),0.0337,1,,
Organic cation transport,Reactome,1,S22A1_HUMAN,10 (11),0.0337,1,,
Neurotransmitter clearance,Reactome,1,S22A1_HUMAN,10 (10),0.0337,1,,
mevalonate pathway,HumanCyc,1,HMCS2_HUMAN,10 (10),0.0337,1,,
RNA Polymerase II Pre-transcription Events,Reactome,2,SPT5H_HUMAN;NCBP1_HUMAN,87 (88),0.0355,1,,
G alpha (12/13) signalling events,Reactome,2,GBG3_HUMAN;ADA1D_HUMAN,87 (89),0.0355,1,,
SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs,Reactome,1,NCBP1_HUMAN,11 (11),0.037,1,,
Methadone Metabolism Pathway,SMPDB,1,NMD3A_HUMAN,11 (11),0.037,1,,
Salivary secretion - Homo sapiens (human),KEGG,2,ADA1D_HUMAN;RYR3_HUMAN,90 (90),0.0378,1,,
Mitochondrial fatty acid synthesis and respiration,Wikipathways,1,OPA1_HUMAN,12 (12),0.0403,1,,
superpathway of geranylgeranyldiphosphate biosynthesis I (via mevalonate),HumanCyc,1,HMCS2_HUMAN,12 (12),0.0403,1,,
Transmission across Chemical Synapses,Reactome,3,SYN3_HUMAN;GBG3_HUMAN;S22A1_HUMAN,224 (224),0.0408,1,,
Circadian entrainment - Homo sapiens (human),KEGG,2,GBG3_HUMAN;RYR3_HUMAN,96 (96),0.0425,1,,
Dissolution of Fibrin Clot,Reactome,1,ANXA2_HUMAN,13 (13),0.0435,1,,
Mitochondrial iron-sulfur cluster biogenesis,Reactome,1,LYRM4_HUMAN,13 (13),0.0435,1,,
MFAP5-mediated ovarian cancer cell motility and invasiveness,Wikipathways,1,RYR3_HUMAN,13 (13),0.0435,1,,
Cell-type Dependent Selectivity of CCK2R Signaling,Wikipathways,1,RYR3_HUMAN,13 (13),0.0435,1,,
L1CAM interactions,Reactome,2,LYPA2_HUMAN;KIF4B_HUMAN,101 (103),0.0465,1,,
Assembly of active LPL and LIPC lipase complexes,Reactome,1,PCSK5_HUMAN,14 (14),0.0468,1,,
Pentose Phosphate Pathway,SMPDB,1,DEOC_HUMAN,14 (14),0.0468,1,,
Glucose-6-phosphate dehydrogenase deficiency,SMPDB,1,DEOC_HUMAN,14 (14),0.0468,1,,
Ribose-5-phosphate isomerase deficiency,SMPDB,1,DEOC_HUMAN,14 (14),0.0468,1,,
Transaldolase deficiency,SMPDB,1,DEOC_HUMAN,14 (14),0.0468,1,,
TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition,Wikipathways,1,SNAI1_HUMAN,14 (14),0.0468,1,,
Pentose phosphate pathway (hexose monophosphate shunt),Reactome,1,DEOC_HUMAN,15 (15),0.0501,1,,
Organic cation/anion/zwitterion transport,Reactome,1,S22A1_HUMAN,15 (16),0.0501,1,,
Histidine Metabolism,SMPDB,1,CRNS1_HUMAN,15 (15),0.0501,1,,
Histidinemia,SMPDB,1,CRNS1_HUMAN,15 (15),0.0501,1,,
eukaryotic protein translation,BioCarta,1,IF2P_HUMAN,16 (17),0.0533,1,,
Butanoate metabolism,INOH,1,HMCS2_HUMAN,17 (17),0.0566,1,,
Glutamatergic synapse - Homo sapiens (human),KEGG,2,GBG3_HUMAN;NMD3A_HUMAN,114 (114),0.0577,1,,
Fructosuria,SMPDB,1,PHP14_HUMAN,18 (18),0.0598,1,,
Serotonin Neurotransmitter Release Cycle,Reactome,1,SYN3_HUMAN,18 (18),0.0598,1,,
Lamivudine Pathway_ Pharmacokinetics/Pharmacodynamics,PharmGKB,1,S22A1_HUMAN,18 (18),0.0598,1,,
Glycogen synthetase deficiency,SMPDB,1,UGDH_HUMAN,18 (18),0.0598,1,,
Glycogenosis_ Type III. Cori disease_ Debrancher glycogenosis,SMPDB,1,UGDH_HUMAN,18 (18),0.0598,1,,
Mucopolysaccharidosis VI. Sly syndrome,SMPDB,1,UGDH_HUMAN,18 (18),0.0598,1,,
Sucrase-isomaltase deficiency,SMPDB,1,UGDH_HUMAN,18 (18),0.0598,1,,
Glycogenosis_ Type IV. Amylopectinosis_ Anderson disease,SMPDB,1,UGDH_HUMAN,18 (18),0.0598,1,,
Glycogenosis_ Type VI. Hers disease,SMPDB,1,UGDH_HUMAN,18 (18),0.0598,1,,
Fructose intolerance_ hereditary,SMPDB,1,PHP14_HUMAN,18 (18),0.0598,1,,
Starch and Sucrose Metabolism,SMPDB,1,UGDH_HUMAN,18 (18),0.0598,1,,
Lamivudine Metabolism Pathway,SMPDB,1,S22A1_HUMAN,18 (18),0.0598,1,,
Fructose and Mannose Degradation,SMPDB,1,PHP14_HUMAN,18 (18),0.0598,1,,
Norepinephrine Neurotransmitter Release Cycle,Reactome,1,S22A1_HUMAN,18 (18),0.0598,1,,
JAK-STAT-Ncore,Signalink,1,IRAK2_HUMAN,18 (18),0.0598,1,,
Processing of Intronless Pre-mRNAs,Reactome,1,NCBP1_HUMAN,19 (19),0.063,1,,
Na+/Cl- dependent neurotransmitter transporters,Reactome,1,S22A1_HUMAN,19 (19),0.063,1,,
Prostacyclin signalling through prostacyclin receptor,Reactome,1,GBG3_HUMAN,19 (19),0.063,1,,
Scavenging by Class A Receptors,Reactome,1,SCAR5_HUMAN,19 (19),0.063,1,,
sprouty regulation of tyrosine kinase signals,BioCarta,1,SPY4_HUMAN,20 (20),0.0662,1,,
JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1,Reactome,1,IRAK2_HUMAN,20 (20),0.0662,1,,
G beta:gamma signalling through PLC beta,Reactome,1,GBG3_HUMAN,20 (20),0.0662,1,,
mRNA Processing,Wikipathways,2,SPT5H_HUMAN;NCBP1_HUMAN,125 (127),0.0679,1,,
EGFR1,NetPath,4,SPY4_HUMAN;PEBP1_HUMAN;ANXA2_HUMAN;PHP14_HUMAN,455 (457),0.0688,1,,
Presynaptic function of Kainate receptors,Reactome,1,GBG3_HUMAN,21 (21),0.0694,1,,
Biosynthesis of specialized proresolving mediators (SPMs),Reactome,1,PTGR1_HUMAN,21 (21),0.0694,1,,
downregulated of mta-3 in er-negative breast tumors,BioCarta,1,SNAI1_HUMAN,21 (21),0.0694,1,,
activated TAK1 mediates p38 MAPK activation,Reactome,1,IRAK2_HUMAN,21 (21),0.0694,1,,
Ardeparin Action Pathway,SMPDB,1,ANT3_HUMAN,21 (21),0.0694,1,,
Heparin Action Pathway,SMPDB,1,ANT3_HUMAN,21 (21),0.0694,1,,
Fondaparinux Action Pathway,SMPDB,1,ANT3_HUMAN,21 (21),0.0694,1,,
Enoxaparin Action Pathway,SMPDB,1,ANT3_HUMAN,21 (21),0.0694,1,,
Synthesis of Leukotrienes (LT) and Eoxins (EX),Reactome,1,PTGR1_HUMAN,22 (23),0.0726,1,,
ADP signalling through P2Y purinoceptor 12,Reactome,1,GBG3_HUMAN,22 (22),0.0726,1,,
Terpenoid backbone biosynthesis - Homo sapiens (human),KEGG,1,HMCS2_HUMAN,22 (22),0.0726,1,,
The canonical retinoid cycle in rods (twilight vision),Reactome,1,STRA6_HUMAN,22 (22),0.0726,1,,
Intrinsic Pathway of Fibrin Clot Formation,Reactome,1,ANT3_HUMAN,22 (22),0.0726,1,,
Common Pathway of Fibrin Clot Formation,Reactome,1,ANT3_HUMAN,22 (22),0.0726,1,,
Pyruvate Dehydrogenase Complex Deficiency,SMPDB,1,GLO2_HUMAN,22 (22),0.0726,1,,
Primary hyperoxaluria II_ PH2,SMPDB,1,GLO2_HUMAN,22 (22),0.0726,1,,
Pyruvate kinase deficiency,SMPDB,1,GLO2_HUMAN,22 (22),0.0726,1,,
Leigh Syndrome,SMPDB,1,GLO2_HUMAN,22 (22),0.0726,1,,
Pyruvate Metabolism,SMPDB,1,GLO2_HUMAN,22 (22),0.0726,1,,
Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency),SMPDB,1,GLO2_HUMAN,22 (22),0.0726,1,,
Tryptophan metabolism,EHMN,1,S22A1_HUMAN,22 (22),0.0726,1,,
Hemostasis,Reactome,5,GBG3_HUMAN;KIF4B_HUMAN;ANXA2_HUMAN;ANT3_HUMAN;PSG3_HUMAN,662 (668),0.0736,1,,
Transport of small molecules,Reactome,5,VPP4_HUMAN;RYR3_HUMAN;S22A1_HUMAN;PCSK5_HUMAN;GBG3_HUMAN,665 (666),0.0748,1,,
Histidine metabolism - Homo sapiens (human),KEGG,1,CRNS1_HUMAN,23 (23),0.0758,1,,
Thromboxane signalling through TP receptor,Reactome,1,GBG3_HUMAN,23 (23),0.0758,1,,
Adrenaline_noradrenaline inhibits insulin secretion,Reactome,1,GBG3_HUMAN,23 (23),0.0758,1,,
Dopamine Neurotransmitter Release Cycle,Reactome,1,SYN3_HUMAN,23 (23),0.0758,1,,
Sympathetic Nerve Pathway (Neuroeffector Junction),PharmGKB,1,ADA1D_HUMAN,23 (23),0.0758,1,,
Butanoate metabolism,EHMN,1,HMCS2_HUMAN,23 (23),0.0758,1,,
ADP signalling through P2Y purinoceptor 1,Reactome,1,GBG3_HUMAN,24 (24),0.0789,1,,
Apelin signaling pathway - Homo sapiens (human),KEGG,2,GBG3_HUMAN;RYR3_HUMAN,137 (137),0.0796,1,,
Glucuronidation,Reactome,1,UGDH_HUMAN,25 (25),0.0821,1,,
Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits,Reactome,1,GBG3_HUMAN,25 (25),0.0821,1,,
superpathway of cholesterol biosynthesis,HumanCyc,1,HMCS2_HUMAN,25 (25),0.0821,1,,
Activation of G protein gated Potassium channels,Reactome,1,GBG3_HUMAN,25 (25),0.0821,1,,
G protein gated Potassium channels,Reactome,1,GBG3_HUMAN,25 (25),0.0821,1,,
Late Phase of HIV Life Cycle,Reactome,2,SPT5H_HUMAN;NCBP1_HUMAN,141 (143),0.0836,1,,
Glucuronidation,Wikipathways,1,UGDH_HUMAN,26 (26),0.0852,1,,
Insulin receptor recycling,Reactome,1,VPP4_HUMAN,26 (26),0.0852,1,,
Glypican 1 network,PID,1,ANT3_HUMAN,26 (26),0.0852,1,,
Endogenous TLR signaling,PID,1,IRAK2_HUMAN,26 (26),0.0852,1,,
FGFR2 alternative splicing,Reactome,1,NCBP1_HUMAN,27 (27),0.0884,1,,
RNA Pol II CTD phosphorylation and interaction with CE during HIV infection,Reactome,1,SPT5H_HUMAN,27 (27),0.0884,1,,
RNA Pol II CTD phosphorylation and interaction with CE,Reactome,1,SPT5H_HUMAN,27 (27),0.0884,1,,
Ascorbate and aldarate metabolism - Homo sapiens (human),KEGG,1,UGDH_HUMAN,27 (27),0.0884,1,,
Collecting duct acid secretion - Homo sapiens (human),KEGG,1,VPP4_HUMAN,27 (27),0.0884,1,,
Recycling pathway of L1,Reactome,1,KIF4B_HUMAN,28 (29),0.0915,1,,
Processing of Capped Intronless Pre-mRNA,Reactome,1,NCBP1_HUMAN,28 (28),0.0915,1,,
G-protein activation,Reactome,1,GBG3_HUMAN,28 (28),0.0915,1,,
Butanoate metabolism - Homo sapiens (human),KEGG,1,HMCS2_HUMAN,28 (28),0.0915,1,,
Anileridine Action Pathway,SMPDB,1,NMD3A_HUMAN,29 (29),0.0946,1,,
Carfentanil Action Pathway,SMPDB,1,NMD3A_HUMAN,29 (29),0.0946,1,,
Hippo signaling pathway - multiple species - Homo sapiens (human),KEGG,1,RASF4_HUMAN,29 (29),0.0946,1,,
Levomethadyl Acetate Action Action Pathway,SMPDB,1,NMD3A_HUMAN,29 (29),0.0946,1,,
Escitalopram Action Pathway,SMPDB,1,NMD3A_HUMAN,29 (29),0.0946,1,,
Levallorphan Action Pathway,SMPDB,1,NMD3A_HUMAN,29 (29),0.0946,1,,
Dimethylthiambutene Action Pathway,SMPDB,1,NMD3A_HUMAN,29 (29),0.0946,1,,
Ethylmorphine Action Pathway,SMPDB,1,NMD3A_HUMAN,29 (29),0.0946,1,,
Pentazocine Action Pathway,SMPDB,1,NMD3A_HUMAN,29 (29),0.0946,1,,
Naltrexone Action Pathway,SMPDB,1,NMD3A_HUMAN,29 (29),0.0946,1,,
Buprenorphine Action Pathway,SMPDB,1,NMD3A_HUMAN,29 (29),0.0946,1,,
Alvimopan Action Pathway,SMPDB,1,NMD3A_HUMAN,29 (29),0.0946,1,,
Naloxone Action Pathway,SMPDB,1,NMD3A_HUMAN,29 (29),0.0946,1,,
Dihydromorphine Action Pathway,SMPDB,1,NMD3A_HUMAN,29 (29),0.0946,1,,
Ketobemidone  Action Pathway,SMPDB,1,NMD3A_HUMAN,29 (29),0.0946,1,,
Mepivacaine Action Pathway,SMPDB,1,NMD3A_HUMAN,29 (29),0.0946,1,,
Chloroprocaine Action Pathway,SMPDB,1,NMD3A_HUMAN,29 (29),0.0946,1,,
Cocaine Action Pathway,SMPDB,1,NMD3A_HUMAN,29 (29),0.0946,1,,
Dibucaine Action Pathway,SMPDB,1,NMD3A_HUMAN,29 (29),0.0946,1,,
Levobupivacaine Action Pathway,SMPDB,1,NMD3A_HUMAN,29 (29),0.0946,1,,
Benzocaine Action Pathway,SMPDB,1,NMD3A_HUMAN,29 (29),0.0946,1,,
Bupivacaine Action Pathway,SMPDB,1,NMD3A_HUMAN,29 (29),0.0946,1,,
Levorphanol Action Pathway,SMPDB,1,NMD3A_HUMAN,29 (29),0.0946,1,,
Propoxyphene Action Pathway,SMPDB,1,NMD3A_HUMAN,29 (29),0.0946,1,,
Tramadol Action Action Pathway,SMPDB,1,NMD3A_HUMAN,29 (29),0.0946,1,,
Diphenoxylate Action Pathway,SMPDB,1,NMD3A_HUMAN,29 (29),0.0946,1,,
Oxycodone Action Pathway,SMPDB,1,NMD3A_HUMAN,29 (29),0.0946,1,,
Oxybuprocaine Action Pathway,SMPDB,1,NMD3A_HUMAN,29 (29),0.0946,1,,
Prilocaine Action Pathway,SMPDB,1,NMD3A_HUMAN,29 (29),0.0946,1,,
Procaine Action Pathway,SMPDB,1,NMD3A_HUMAN,29 (29),0.0946,1,,
Proparacaine Action Pathway,SMPDB,1,NMD3A_HUMAN,29 (29),0.0946,1,,
Ropivacaine Action Pathway,SMPDB,1,NMD3A_HUMAN,29 (29),0.0946,1,,
Alfentanil Action Pathway,SMPDB,1,NMD3A_HUMAN,29 (29),0.0946,1,,
Oxymorphone Action Pathway,SMPDB,1,NMD3A_HUMAN,29 (29),0.0946,1,,
Hydrocodone Action Pathway,SMPDB,1,NMD3A_HUMAN,29 (29),0.0946,1,,
Hydromorphone Action Pathway,SMPDB,1,NMD3A_HUMAN,29 (29),0.0946,1,,
Sufentanil Action Pathway,SMPDB,1,NMD3A_HUMAN,29 (29),0.0946,1,,
Remifentanil Action Pathway,SMPDB,1,NMD3A_HUMAN,29 (29),0.0946,1,,
Fentanyl Action Pathway,SMPDB,1,NMD3A_HUMAN,29 (29),0.0946,1,,
3-Methylthiofentanyl Action Pathway,SMPDB,1,NMD3A_HUMAN,29 (29),0.0946,1,,
Methadyl Acetate Action Pathway,SMPDB,1,NMD3A_HUMAN,29 (29),0.0946,1,,
Dezocine Action Pathway,SMPDB,1,NMD3A_HUMAN,29 (29),0.0946,1,,
HIV Life Cycle,Reactome,2,SPT5H_HUMAN;NCBP1_HUMAN,154 (156),0.0971,1,,
3-Methylcrotonyl Coa Carboxylase Deficiency Type I,SMPDB,1,HMCS2_HUMAN,30 (30),0.0977,1,,
Plasma lipoprotein remodeling,Reactome,1,PCSK5_HUMAN,30 (30),0.0977,1,,
Pyruvate metabolism,Reactome,1,GLO2_HUMAN,30 (30),0.0977,1,,
Amine compound SLC transporters,Reactome,1,S22A1_HUMAN,30 (30),0.0977,1,,
Fatty acid elongation - Homo sapiens (human),KEGG,1,AB17A_HUMAN,30 (30),0.0977,1,,
Activation of kainate receptors upon glutamate binding,Reactome,1,GBG3_HUMAN,30 (30),0.0977,1,,
Pentose phosphate pathway - Homo sapiens (human),KEGG,1,DEOC_HUMAN,30 (30),0.0977,1,,
Desipramine Action Pathway,SMPDB,1,NMD3A_HUMAN,30 (30),0.0977,1,,
3-Methylglutaconic Aciduria Type I,SMPDB,1,HMCS2_HUMAN,30 (30),0.0977,1,,
Valine_ Leucine and Isoleucine Degradation,SMPDB,1,HMCS2_HUMAN,30 (30),0.0977,1,,
2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency,SMPDB,1,HMCS2_HUMAN,30 (30),0.0977,1,,
Nalbuphine Action Pathway,SMPDB,1,NMD3A_HUMAN,30 (30),0.0977,1,,
Isovaleric Aciduria,SMPDB,1,HMCS2_HUMAN,30 (30),0.0977,1,,
Propionic Acidemia,SMPDB,1,HMCS2_HUMAN,30 (30),0.0977,1,,
Maple Syrup Urine Disease,SMPDB,1,HMCS2_HUMAN,30 (30),0.0977,1,,
3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency,SMPDB,1,HMCS2_HUMAN,30 (30),0.0977,1,,
Isobutyryl-coa dehydrogenase deficiency,SMPDB,1,HMCS2_HUMAN,30 (30),0.0977,1,,
3-hydroxyisobutyric aciduria,SMPDB,1,HMCS2_HUMAN,30 (30),0.0977,1,,
3-hydroxyisobutyric acid dehydrogenase deficiency,SMPDB,1,HMCS2_HUMAN,30 (30),0.0977,1,,
Isovaleric acidemia,SMPDB,1,HMCS2_HUMAN,30 (30),0.0977,1,,
Methylmalonate Semialdehyde Dehydrogenase Deficiency,SMPDB,1,HMCS2_HUMAN,30 (30),0.0977,1,,
Methylmalonic Aciduria,SMPDB,1,HMCS2_HUMAN,30 (30),0.0977,1,,
3-Methylglutaconic Aciduria Type IV,SMPDB,1,HMCS2_HUMAN,30 (30),0.0977,1,,
3-Methylglutaconic Aciduria Type III,SMPDB,1,HMCS2_HUMAN,30 (30),0.0977,1,,
Beta-Ketothiolase Deficiency,SMPDB,1,HMCS2_HUMAN,30 (30),0.0977,1,,
Myometrial Relaxation and Contraction Pathways,Wikipathways,2,GBG3_HUMAN;RYR3_HUMAN,155 (155),0.0981,1,,
Transferrin endocytosis and recycling,Reactome,1,VPP4_HUMAN,31 (31),0.101,1,,
Signal amplification,Reactome,1,GBG3_HUMAN,31 (31),0.101,1,,
Lidocaine (Local Anaesthetic) Action Pathway,SMPDB,1,NMD3A_HUMAN,31 (31),0.101,1,,
beta-Alanine metabolism - Homo sapiens (human),KEGG,1,CRNS1_HUMAN,31 (31),0.101,1,,
Inwardly rectifying K+ channels,Reactome,1,GBG3_HUMAN,31 (31),0.101,1,,
ROS_ RNS production in phagocytes,Reactome,1,VPP4_HUMAN,32 (32),0.104,1,,
Thrombin signalling through proteinase activated receptors (PARs),Reactome,1,GBG3_HUMAN,32 (32),0.104,1,,
TAK1 activates NFkB by phosphorylation and activation of IKKs complex,Reactome,1,IRAK2_HUMAN,32 (32),0.104,1,,
Codeine Action Pathway,SMPDB,1,NMD3A_HUMAN,32 (32),0.104,1,,
Valine Leucine Isoleucine degradation,INOH,1,HMCS2_HUMAN,32 (32),0.104,1,,
Heroin Action Pathway,SMPDB,1,NMD3A_HUMAN,32 (32),0.104,1,,
Initiation of transcription and translation elongation at the HIV-1 LTR,Wikipathways,1,SPT5H_HUMAN,32 (32),0.104,1,,
Monoamine GPCRs,Wikipathways,1,ADA1D_HUMAN,33 (34),0.107,1,,
Glucagon signaling in metabolic regulation,Reactome,1,GBG3_HUMAN,33 (33),0.107,1,,
NOD1/2 Signaling Pathway,Reactome,1,IRAK2_HUMAN,33 (33),0.107,1,,
Transport of the SLBP independent Mature mRNA,Reactome,1,NCBP1_HUMAN,33 (33),0.107,1,,
Glucagon-type ligand receptors,Reactome,1,GBG3_HUMAN,33 (33),0.107,1,,
Imipramine Action Pathway,SMPDB,1,NMD3A_HUMAN,33 (33),0.107,1,,
Pyruvate metabolism,INOH,1,GLO2_HUMAN,34 (34),0.11,1,,
Signaling by high-kinase activity BRAF mutants,Reactome,1,PEBP1_HUMAN,34 (34),0.11,1,,
Transport of the SLBP Dependant Mature mRNA,Reactome,1,NCBP1_HUMAN,34 (34),0.11,1,,
Pentose and glucuronate interconversions - Homo sapiens (human),KEGG,1,UGDH_HUMAN,34 (34),0.11,1,,
Fluoxetine Action Pathway,SMPDB,1,NMD3A_HUMAN,34 (34),0.11,1,,
Prostaglandin formation from arachidonate,EHMN,1,S22A1_HUMAN,34 (34),0.11,1,,
RNA transport - Homo sapiens (human),KEGG,2,IF2P_HUMAN;NCBP1_HUMAN,166 (171),0.11,1,,
Smooth Muscle Contraction,Reactome,1,ANXA2_HUMAN,35 (35),0.113,1,,
Glucagon-like Peptide-1 (GLP1) regulates insulin secretion,Reactome,1,GBG3_HUMAN,35 (35),0.113,1,,
Signaling by RAS mutants,Reactome,1,PEBP1_HUMAN,36 (36),0.116,1,,
Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation,Wikipathways,1,ANXA2_HUMAN,36 (36),0.116,1,,
Citalopram Action Pathway,SMPDB,1,NMD3A_HUMAN,36 (36),0.116,1,,
Nicotine Action Pathway,SMPDB,1,NMD3A_HUMAN,36 (36),0.116,1,,
Methadone Action Pathway,SMPDB,1,NMD3A_HUMAN,36 (36),0.116,1,,
Fibrin Complement Receptor 3 Signaling Pathway,Wikipathways,1,IRAK2_HUMAN,36 (36),0.116,1,,
Tat-mediated HIV elongation arrest and recovery,Reactome,1,SPT5H_HUMAN,37 (38),0.119,1,,
Pausing and recovery of Tat-mediated HIV elongation,Reactome,1,SPT5H_HUMAN,37 (38),0.119,1,,
MAP2K and MAPK activation,Reactome,1,PEBP1_HUMAN,38 (38),0.122,1,,
Signaling by moderate kinase activity BRAF mutants,Reactome,1,PEBP1_HUMAN,38 (38),0.122,1,,
Paradoxical activation of RAF signaling by kinase inactive BRAF,Reactome,1,PEBP1_HUMAN,38 (38),0.122,1,,
Tuberculosis - Homo sapiens (human),KEGG,2,IRAK2_HUMAN;VPP4_HUMAN,178 (179),0.123,1,,
Ion channel transport,Reactome,2,VPP4_HUMAN;RYR3_HUMAN,179 (179),0.125,1,,
HIV elongation arrest and recovery,Reactome,1,SPT5H_HUMAN,39 (40),0.125,1,,
Pausing and recovery of HIV elongation,Reactome,1,SPT5H_HUMAN,39 (40),0.125,1,,
Pyruvate metabolism - Homo sapiens (human),KEGG,1,GLO2_HUMAN,39 (39),0.125,1,,
Activation of GABAB receptors,Reactome,1,GBG3_HUMAN,39 (39),0.125,1,,
Formation of Fibrin Clot (Clotting Cascade),Reactome,1,ANT3_HUMAN,39 (39),0.125,1,,
GABA B receptor activation,Reactome,1,GBG3_HUMAN,39 (39),0.125,1,,
Alcoholism - Homo sapiens (human),KEGG,2,GBG3_HUMAN;NMD3A_HUMAN,180 (180),0.126,1,,
Transport of Mature mRNA Derived from an Intronless Transcript,Reactome,1,NCBP1_HUMAN,40 (40),0.128,1,,
Nicotine addiction - Homo sapiens (human),KEGG,1,NMD3A_HUMAN,40 (40),0.128,1,,
Negative regulation of MAPK pathway,Reactome,1,PEBP1_HUMAN,40 (40),0.128,1,,
Vasopressin regulates renal water homeostasis via Aquaporins,Reactome,1,GBG3_HUMAN,40 (40),0.128,1,,
Neuronal System,Reactome,3,SYN3_HUMAN;GBG3_HUMAN;S22A1_HUMAN,368 (368),0.13,1,,
Gastrin,NetPath,1,ANXA2_HUMAN,41 (41),0.131,1,,
Aurora B signaling,PID,1,PEBP1_HUMAN,41 (41),0.131,1,,
Transport of Mature mRNAs Derived from Intronless Transcripts,Reactome,1,NCBP1_HUMAN,41 (41),0.131,1,,
Glycine Serine metabolism,INOH,1,PTGR1_HUMAN,41 (41),0.131,1,,
Binding and Uptake of Ligands by Scavenger Receptors,Reactome,1,SCAR5_HUMAN,41 (41),0.131,1,,
Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha),Wikipathways,1,HMCS2_HUMAN,41 (41),0.131,1,,
Calcium signaling pathway - Homo sapiens (human),KEGG,2,ADA1D_HUMAN;RYR3_HUMAN,185 (186),0.131,1,,
Kinesins,Reactome,1,KIF4B_HUMAN,43 (43),0.137,1,,
Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding,Reactome,1,GBG3_HUMAN,43 (43),0.137,1,,
Amine ligand-binding receptors,Reactome,1,ADA1D_HUMAN,43 (43),0.137,1,,
Prostaglandin Synthesis and Regulation,Wikipathways,1,ANXA2_HUMAN,44 (44),0.14,1,,
Morphine Action Pathway,SMPDB,1,NMD3A_HUMAN,44 (44),0.14,1,,
Structural Pathway of Interleukin 1 (IL-1),Wikipathways,1,IRAK2_HUMAN,44 (44),0.14,1,,
Integrin-linked kinase signaling,PID,1,SNAI1_HUMAN,45 (45),0.143,1,,
HIV Infection,Reactome,2,SPT5H_HUMAN;NCBP1_HUMAN,195 (197),0.143,1,,
Muscle contraction,Reactome,2,ANXA2_HUMAN;RYR3_HUMAN,195 (195),0.143,1,,
Nucleotide-binding domain_ leucine rich repeat containing receptor (NLR) signaling pathways,Reactome,1,IRAK2_HUMAN,47 (47),0.149,1,,
Validated transcriptional targets of deltaNp63 isoforms,PID,1,RAD_HUMAN,47 (48),0.149,1,,
Transcriptional regulation of white adipocyte differentiation,Reactome,1,MD13L_HUMAN,47 (47),0.149,1,,
G alpha (z) signalling events,Reactome,1,GBG3_HUMAN,47 (47),0.149,1,,
Rett syndrome causing genes,Wikipathways,1,CECR2_HUMAN,48 (48),0.152,1,,
Histidine_ lysine_ phenylalanine_ tyrosine_ proline and tryptophan catabolism,Reactome,1,CRNS1_HUMAN,48 (49),0.152,1,,
Valine_ leucine and isoleucine degradation - Homo sapiens (human),KEGG,1,HMCS2_HUMAN,48 (48),0.152,1,,
Amino sugar and nucleotide sugar metabolism - Homo sapiens (human),KEGG,1,UGDH_HUMAN,48 (48),0.152,1,,
G beta:gamma signalling through PI3Kgamma,Reactome,1,GBG3_HUMAN,48 (48),0.152,1,,
Arginine and proline metabolism - Homo sapiens (human),KEGG,1,CRNS1_HUMAN,49 (50),0.155,1,,
Cocaine addiction - Homo sapiens (human),KEGG,1,NMD3A_HUMAN,49 (49),0.155,1,,
Aquaporin-mediated transport,Reactome,1,GBG3_HUMAN,49 (49),0.155,1,,
Vibrio cholerae infection - Homo sapiens (human),KEGG,1,VPP4_HUMAN,50 (50),0.158,1,,
Translation Factors,Wikipathways,1,IF2P_HUMAN,50 (50),0.158,1,,
Synaptic Vesicle Pathway,Wikipathways,1,SYN3_HUMAN,51 (51),0.16,1,,
G-protein beta:gamma signalling,Reactome,1,GBG3_HUMAN,51 (51),0.16,1,,
snRNP Assembly,Reactome,1,NCBP1_HUMAN,52 (52),0.163,1,,
Ion homeostasis,Reactome,1,RYR3_HUMAN,52 (52),0.163,1,,
Metabolism of non-coding RNA,Reactome,1,NCBP1_HUMAN,52 (52),0.163,1,,
mRNA Splicing - Minor Pathway,Reactome,1,NCBP1_HUMAN,52 (52),0.163,1,,
G alpha (q) signalling events,Reactome,2,GBG3_HUMAN;ADA1D_HUMAN,213 (213),0.165,1,,
Ca2+ pathway,Reactome,1,GBG3_HUMAN,53 (53),0.166,1,,
Pyruvate metabolism and Citric Acid (TCA) cycle,Reactome,1,GLO2_HUMAN,54 (54),0.169,1,,
IL1,NetPath,1,IRAK2_HUMAN,54 (54),0.169,1,,
GABA receptor activation,Reactome,1,GBG3_HUMAN,55 (55),0.172,1,,
Antiarrhythmic Pathway_ Pharmacodynamics,PharmGKB,1,ADA1D_HUMAN,55 (55),0.172,1,,
IL-1 signaling pathway,Wikipathways,1,IRAK2_HUMAN,55 (55),0.172,1,,
Signaling by Receptor Tyrosine Kinases,Reactome,3,VPP4_HUMAN;PCSK5_HUMAN;NCBP1_HUMAN,423 (423),0.175,1,,
EGF-Ncore,Signalink,1,PEBP1_HUMAN,57 (57),0.178,1,,
Iron uptake and transport,Reactome,1,VPP4_HUMAN,58 (58),0.18,1,,
Signaling by BRAF and RAF fusions,Reactome,1,PEBP1_HUMAN,58 (58),0.18,1,,
mRNA 3_-end processing,Reactome,1,NCBP1_HUMAN,58 (58),0.18,1,,
Complement and Coagulation Cascades,Wikipathways,1,ANT3_HUMAN,59 (59),0.183,1,,
Kit receptor signaling pathway,Wikipathways,1,SNAI1_HUMAN,59 (59),0.183,1,,
Interleukin-1 signaling,Reactome,1,IRAK2_HUMAN,60 (60),0.186,1,,
Dengue-2 Interactions with Complement and Coagulation Cascades,Wikipathways,1,ANT3_HUMAN,60 (60),0.186,1,,
Arachidonic acid metabolism,Reactome,1,PTGR1_HUMAN,61 (62),0.189,1,,
Oncogenic MAPK signaling,Reactome,1,PEBP1_HUMAN,61 (61),0.189,1,,
Oxidation by Cytochrome P450,Wikipathways,1,C27C1_HUMAN,62 (62),0.192,1,,
Regulation of PTEN gene transcription,Reactome,1,SNAI1_HUMAN,62 (62),0.192,1,,
Synaptic vesicle cycle - Homo sapiens (human),KEGG,1,VPP4_HUMAN,63 (63),0.194,1,,
Interleukin-17 signaling,Reactome,1,IRAK2_HUMAN,65 (65),0.2,1,,
Validated targets of C-MYC transcriptional repression,PID,1,HMCS2_HUMAN,65 (74),0.2,1,,
MAP kinase activation,Reactome,1,IRAK2_HUMAN,65 (65),0.2,1,,
Beta-agonist/Beta-blocker Pathway_ Pharmacodynamics,PharmGKB,1,GBG3_HUMAN,65 (66),0.2,1,,
Human Thyroid Stimulating Hormone (TSH) signaling pathway,Wikipathways,1,TTF2_HUMAN,66 (66),0.203,1,,
Histone Modifications,Wikipathways,1,SETD6_HUMAN,66 (66),0.203,1,,
Cleavage of Growing Transcript in the Termination Region ,Reactome,1,NCBP1_HUMAN,67 (67),0.205,1,,
RNA Polymerase II Transcription Termination,Reactome,1,NCBP1_HUMAN,67 (67),0.205,1,,
Retinol metabolism - Homo sapiens (human),KEGG,1,C27C1_HUMAN,67 (67),0.205,1,,
Epithelial cell signaling in Helicobacter pylori infection - Homo sapiens (human),KEGG,1,VPP4_HUMAN,68 (68),0.208,1,,
Amphetamine addiction - Homo sapiens (human),KEGG,1,NMD3A_HUMAN,68 (68),0.208,1,,
PPAR signaling pathway,Wikipathways,1,HMCS2_HUMAN,68 (68),0.208,1,,
TP53 Regulates Transcription of DNA Repair Genes,Reactome,1,SPT5H_HUMAN,69 (70),0.211,1,,
Plasma lipoprotein assembly_ remodeling_ and clearance,Reactome,1,PCSK5_HUMAN,69 (69),0.211,1,,
Infectious disease,Reactome,2,SPT5H_HUMAN;NCBP1_HUMAN,251 (253),0.211,1,,
RNA polymerase II transcribes snRNA genes,Reactome,1,NCBP1_HUMAN,70 (77),0.214,1,,
Regulation of insulin secretion,Reactome,1,GBG3_HUMAN,70 (70),0.214,1,,
Metabolism,Reactome,9,GBG3_HUMAN;CRNS1_HUMAN;PTGR1_HUMAN;LYRM4_HUMAN;S22A1_HUMAN;GLO2_HUMAN;HMCS2_HUMAN;UGDH_HUMAN;DEOC_HUMAN,1954 (1972),0.215,1,,
Bile secretion - Homo sapiens (human),KEGG,1,S22A1_HUMAN,71 (71),0.216,1,,
PKMTs methylate histone lysines,Reactome,1,SETD6_HUMAN,72 (73),0.219,1,,
Adherens junction - Homo sapiens (human),KEGG,1,SNAI1_HUMAN,72 (72),0.219,1,,
Signaling by FGFR2,Reactome,1,NCBP1_HUMAN,73 (73),0.222,1,,
Transport of Mature mRNA derived from an Intron-Containing Transcript,Reactome,1,NCBP1_HUMAN,73 (73),0.222,1,,
PPAR signaling pathway - Homo sapiens (human),KEGG,1,HMCS2_HUMAN,74 (74),0.224,1,,
Thyroid hormone synthesis - Homo sapiens (human),KEGG,1,TTF2_HUMAN,74 (74),0.224,1,,
Signaling by Insulin receptor,Reactome,1,VPP4_HUMAN,75 (75),0.227,1,,
Interleukin-1 family signaling,Reactome,1,IRAK2_HUMAN,77 (77),0.232,1,,
p73 transcription factor network,PID,1,GLO2_HUMAN,79 (79),0.238,1,,
Complement and coagulation cascades - Homo sapiens (human),KEGG,1,ANT3_HUMAN,79 (79),0.238,1,,
Alzheimers Disease,Wikipathways,1,RYR3_HUMAN,79 (145),0.238,1,,
Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met),PID,1,SNAI1_HUMAN,81 (82),0.243,1,,
Validated targets of C-MYC transcriptional activation,PID,1,SNAI1_HUMAN,81 (87),0.243,1,,
Opioid Signalling,Reactome,1,GBG3_HUMAN,81 (82),0.243,1,,
Neuroactive ligand-receptor interaction - Homo sapiens (human),KEGG,2,ADA1D_HUMAN;NMD3A_HUMAN,277 (277),0.244,1,,
COPI-dependent Golgi-to-ER retrograde traffic,Reactome,1,KIF4B_HUMAN,82 (82),0.245,1,,
Transport of Mature Transcript to Cytoplasm,Reactome,1,NCBP1_HUMAN,82 (82),0.245,1,,
Disease,Reactome,3,SPT5H_HUMAN;NCBP1_HUMAN;PEBP1_HUMAN,508 (510),0.251,1,,
Transport of bile salts and organic acids_ metal ions and amine compounds,Reactome,1,S22A1_HUMAN,86 (87),0.256,1,,
Signaling by FGFR,Reactome,1,NCBP1_HUMAN,87 (87),0.258,1,,
MyD88 cascade initiated on plasma membrane,Reactome,1,IRAK2_HUMAN,87 (87),0.258,1,,
Toll Like Receptor 10 (TLR10) Cascade,Reactome,1,IRAK2_HUMAN,87 (87),0.258,1,,
Toll Like Receptor 5 (TLR5) Cascade,Reactome,1,IRAK2_HUMAN,87 (87),0.258,1,,
GABAergic synapse - Homo sapiens (human),KEGG,1,GBG3_HUMAN,88 (88),0.261,1,,
TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation,Reactome,1,IRAK2_HUMAN,88 (88),0.261,1,,
Pancreatic adenocarcinoma pathway,Wikipathways,1,PEBP1_HUMAN,89 (89),0.263,1,,
Rheumatoid arthritis - Homo sapiens (human),KEGG,1,VPP4_HUMAN,89 (90),0.263,1,,
Signaling by NTRKs,Reactome,1,PCSK5_HUMAN,89 (89),0.263,1,,
Platelet homeostasis,Reactome,1,GBG3_HUMAN,89 (89),0.263,1,,
Toll Like Receptor 7/8 (TLR7/8) Cascade,Reactome,1,IRAK2_HUMAN,90 (90),0.266,1,,
MyD88 dependent cascade initiated on endosome,Reactome,1,IRAK2_HUMAN,90 (90),0.266,1,,
mRNA surveillance pathway - Homo sapiens (human),KEGG,1,NCBP1_HUMAN,91 (91),0.268,1,,
Morphine addiction - Homo sapiens (human),KEGG,1,GBG3_HUMAN,91 (91),0.268,1,,
Amino Acid metabolism,Wikipathways,1,HMCS2_HUMAN,91 (91),0.268,1,,
GPCRs_ Other,Wikipathways,1,ADA1D_HUMAN,92 (101),0.271,1,,
Beta-catenin independent WNT signaling,Reactome,1,GBG3_HUMAN,92 (92),0.271,1,,
G Protein Signaling Pathways,Wikipathways,1,GBG3_HUMAN,92 (92),0.271,1,,
Integration of energy metabolism,Reactome,1,GBG3_HUMAN,94 (94),0.276,1,,
Toll Like Receptor 9 (TLR9) Cascade,Reactome,1,IRAK2_HUMAN,94 (94),0.276,1,,
Class B/2 (Secretin family receptors),Reactome,1,GBG3_HUMAN,95 (96),0.278,1,,
PTEN Regulation,Reactome,1,SNAI1_HUMAN,96 (96),0.281,1,,
Toll Like Receptor 3 (TLR3) Cascade,Reactome,1,IRAK2_HUMAN,97 (97),0.283,1,,
Chaperonin-mediated protein folding,Reactome,1,GBG3_HUMAN,97 (97),0.283,1,,
Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),Reactome,1,NCBP1_HUMAN,97 (106),0.283,1,,
Glycerophospholipid metabolism - Homo sapiens (human),KEGG,1,LYPA2_HUMAN,97 (97),0.283,1,,
MyD88:Mal cascade initiated on plasma membrane,Reactome,1,IRAK2_HUMAN,97 (97),0.283,1,,
Toll Like Receptor TLR1:TLR2 Cascade,Reactome,1,IRAK2_HUMAN,97 (97),0.283,1,,
Toll Like Receptor TLR6:TLR2 Cascade,Reactome,1,IRAK2_HUMAN,97 (97),0.283,1,,
Toll Like Receptor 2 (TLR2) Cascade,Reactome,1,IRAK2_HUMAN,97 (97),0.283,1,,
Choline metabolism in cancer - Homo sapiens (human),KEGG,1,S22A1_HUMAN,99 (99),0.288,1,,
Potassium Channels,Reactome,1,GBG3_HUMAN,100 (100),0.291,1,,
TRIF(TICAM1)-mediated TLR4 signaling ,Reactome,1,IRAK2_HUMAN,101 (101),0.293,1,,
MyD88-independent TLR4 cascade ,Reactome,1,IRAK2_HUMAN,101 (101),0.293,1,,
Neural Crest Differentiation,Wikipathways,1,SNAI1_HUMAN,101 (101),0.293,1,,
Stimuli-sensing channels,Reactome,1,RYR3_HUMAN,102 (102),0.296,1,,
Visual phototransduction,Reactome,1,STRA6_HUMAN,102 (102),0.296,1,,
Protein folding,Reactome,1,GBG3_HUMAN,103 (103),0.298,1,,
Liver steatosis AOP,Wikipathways,1,HMCS2_HUMAN,103 (103),0.298,1,,
ErbB1 downstream signaling,PID,1,PEBP1_HUMAN,106 (107),0.305,1,,
Post-translational protein phosphorylation,Reactome,1,ANT3_HUMAN,108 (110),0.31,1,,
Nonsense-Mediated Decay (NMD),Reactome,1,NCBP1_HUMAN,109 (118),0.312,1,,
Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC),Reactome,1,NCBP1_HUMAN,109 (118),0.312,1,,
Cholinergic synapse - Homo sapiens (human),KEGG,1,GBG3_HUMAN,112 (112),0.32,1,,
Phase II - Conjugation of compounds,Reactome,1,UGDH_HUMAN,113 (115),0.322,1,,
Serotonergic synapse - Homo sapiens (human),KEGG,1,GBG3_HUMAN,115 (115),0.327,1,,
GTP hydrolysis and joining of the 60S ribosomal subunit,Reactome,1,IF2P_HUMAN,116 (126),0.329,1,,
Thyroid hormone signaling pathway - Homo sapiens (human),KEGG,1,MD13L_HUMAN,116 (116),0.329,1,,
Golgi-to-ER retrograde transport,Reactome,1,KIF4B_HUMAN,116 (116),0.329,1,,
Apoptosis,Reactome,1,OPA1_HUMAN,118 (118),0.334,1,,
Neurotrophin signaling pathway - Homo sapiens (human),KEGG,1,IRAK2_HUMAN,119 (119),0.336,1,,
Programmed Cell Death,Reactome,1,OPA1_HUMAN,121 (121),0.34,1,,
Vascular smooth muscle contraction - Homo sapiens (human),KEGG,1,ADA1D_HUMAN,121 (121),0.34,1,,
miR-targeted genes in squamous cell - TarBase,Wikipathways,1,ANXA2_HUMAN,122 (158),0.343,1,,
Axon guidance,Reactome,2,LYPA2_HUMAN;KIF4B_HUMAN,356 (358),0.345,1,,
Cap-dependent Translation Initiation,Reactome,1,IF2P_HUMAN,123 (133),0.345,1,,
Eukaryotic Translation Initiation,Reactome,1,IF2P_HUMAN,123 (133),0.345,1,,
Lysosome - Homo sapiens (human),KEGG,1,VPP4_HUMAN,123 (123),0.345,1,,
Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs),Reactome,1,ANT3_HUMAN,125 (127),0.349,1,,
miR-targeted genes in leukocytes - TarBase,Wikipathways,1,ANXA2_HUMAN,126 (154),0.352,1,,
Toll Like Receptor 4 (TLR4) Cascade,Reactome,1,IRAK2_HUMAN,127 (127),0.354,1,,
Developmental Biology,Reactome,3,LYPA2_HUMAN;KIF4B_HUMAN;MD13L_HUMAN,618 (620),0.354,1,,
Relaxin signaling pathway - Homo sapiens (human),KEGG,1,GBG3_HUMAN,130 (130),0.361,1,,
Factors involved in megakaryocyte development and platelet production,Reactome,1,KIF4B_HUMAN,131 (131),0.363,1,,
Dopaminergic synapse - Homo sapiens (human),KEGG,1,GBG3_HUMAN,131 (131),0.363,1,,
Cardiac conduction,Reactome,1,RYR3_HUMAN,131 (131),0.363,1,,
Oxidative phosphorylation - Homo sapiens (human),KEGG,1,VPP4_HUMAN,133 (133),0.367,1,,
Spliceosome - Homo sapiens (human),KEGG,1,NCBP1_HUMAN,133 (134),0.367,1,,
Regulation of toll-like receptor signaling pathway,Wikipathways,1,IRAK2_HUMAN,139 (143),0.38,1,,
NRF2 pathway,Wikipathways,1,PTGR1_HUMAN,142 (142),0.387,1,,
Adrenergic signaling in cardiomyocytes - Homo sapiens (human),KEGG,1,ADA1D_HUMAN,144 (144),0.391,1,,
Mesodermal Commitment Pathway,Wikipathways,1,SNAI1_HUMAN,146 (153),0.395,1,,
G alpha (i) signalling events,Reactome,2,GBG3_HUMAN;STRA6_HUMAN,399 (400),0.398,1,,
Retrograde endocannabinoid signaling - Homo sapiens (human),KEGG,1,GBG3_HUMAN,148 (148),0.399,1,,
Phagosome - Homo sapiens (human),KEGG,1,VPP4_HUMAN,151 (152),0.405,1,,
Oxytocin signaling pathway - Homo sapiens (human),KEGG,1,RYR3_HUMAN,152 (152),0.407,1,,
Neurotransmitter receptors and postsynaptic signal transmission,Reactome,1,GBG3_HUMAN,153 (153),0.41,1,,
Toll-Like Receptors Cascades,Reactome,1,IRAK2_HUMAN,154 (154),0.412,1,,
Epithelial to mesenchymal transition in colorectal cancer,Wikipathways,1,SNAI1_HUMAN,159 (160),0.422,1,,
Insulin Signaling,Wikipathways,1,RAD_HUMAN,160 (160),0.424,1,,
EGF-EGFR Signaling Pathway,Wikipathways,1,PEBP1_HUMAN,162 (162),0.428,1,,
cGMP-PKG signaling pathway - Homo sapiens (human),KEGG,1,ADA1D_HUMAN,163 (163),0.43,1,,
Chemokine signaling pathway,Wikipathways,1,GBG3_HUMAN,165 (165),0.434,1,,
Alzheimer disease - Homo sapiens (human),KEGG,1,RYR3_HUMAN,171 (171),0.445,1,,
The citric acid (TCA) cycle and respiratory electron transport,Reactome,1,GLO2_HUMAN,173 (173),0.449,1,,
mRNA Splicing - Major Pathway,Reactome,1,NCBP1_HUMAN,178 (178),0.459,1,,
Metapathway biotransformation Phase I and II,Wikipathways,1,C27C1_HUMAN,184 (186),0.47,1,,
Ras Signaling,Wikipathways,1,GBG3_HUMAN,184 (184),0.47,1,,
IL-7 signaling,INOH,1,IRAK2_HUMAN,185 (185),0.472,1,,
EPO signaling,INOH,1,IRAK2_HUMAN,186 (186),0.473,1,,
Kaposi sarcoma-associated herpesvirus infection - Homo sapiens (human),KEGG,1,GBG3_HUMAN,186 (186),0.473,1,,
mRNA Splicing,Reactome,1,NCBP1_HUMAN,186 (186),0.473,1,,
Intra-Golgi and retrograde Golgi-to-ER traffic,Reactome,1,KIF4B_HUMAN,186 (186),0.473,1,,
Fatty acid metabolism,Reactome,1,PTGR1_HUMAN,187 (189),0.475,1,,
GPCR ligand binding,Reactome,2,GBG3_HUMAN;ADA1D_HUMAN,465 (466),0.475,1,,
VEGF,INOH,1,IRAK2_HUMAN,188 (188),0.477,1,,
Chemokine signaling pathway - Homo sapiens (human),KEGG,1,GBG3_HUMAN,189 (189),0.479,1,,
Huntington disease - Homo sapiens (human),KEGG,1,DYH10_HUMAN,193 (193),0.486,1,,
RAF/MAP kinase cascade,Reactome,1,PEBP1_HUMAN,196 (197),0.491,1,,
cAMP signaling pathway - Homo sapiens (human),KEGG,1,NMD3A_HUMAN,199 (199),0.497,1,,
Innate Immune System,Reactome,4,IRAK2_HUMAN;VPP4_HUMAN;ANXA2_HUMAN;DEOC_HUMAN,1067 (1077),0.501,1,,
Neutrophil degranulation,Reactome,2,ANXA2_HUMAN;DEOC_HUMAN,488 (490),0.501,1,,
MAPK1/MAPK3 signaling,Reactome,1,PEBP1_HUMAN,202 (203),0.502,1,,
Human immunodeficiency virus 1 infection - Homo sapiens (human),KEGG,1,GBG3_HUMAN,212 (212),0.519,1,,
Ciliary landscape,Wikipathways,1,IF2P_HUMAN,213 (213),0.521,1,,
Cell surface interactions at the vascular wall,Reactome,1,PSG3_HUMAN,213 (219),0.521,1,,
PIP3 activates AKT signaling,Reactome,1,SNAI1_HUMAN,214 (214),0.522,1,,
Purine metabolism,EHMN,1,VPP4_HUMAN,223 (223),0.537,1,,
Human cytomegalovirus infection - Homo sapiens (human),KEGG,1,GBG3_HUMAN,225 (225),0.54,1,,
Biological oxidations,Reactome,1,UGDH_HUMAN,229 (231),0.547,1,,
Ras signaling pathway - Homo sapiens (human),KEGG,1,GBG3_HUMAN,232 (232),0.551,1,,
MAPK family signaling cascades,Reactome,1,PEBP1_HUMAN,234 (237),0.554,1,,
Processing of Capped Intron-Containing Pre-mRNA,Reactome,1,NCBP1_HUMAN,240 (240),0.564,1,,
TCR,NetPath,1,ANXA2_HUMAN,241 (245),0.565,1,,
SLC-mediated transmembrane transport,Reactome,1,S22A1_HUMAN,244 (245),0.57,1,,
Intracellular signaling by second messengers,Reactome,1,SNAI1_HUMAN,245 (245),0.571,1,,
Diseases of signal transduction,Reactome,1,PEBP1_HUMAN,248 (248),0.576,1,,
Signaling by Interleukins,Reactome,1,IRAK2_HUMAN,254 (254),0.584,1,,
Platelet activation_ signaling and aggregation,Reactome,1,GBG3_HUMAN,259 (260),0.592,1,,
Metabolism of RNA,Reactome,2,SPT5H_HUMAN;NCBP1_HUMAN,577 (586),0.593,1,,
GPCRs_ Class A Rhodopsin-like,Wikipathways,1,ADA1D_HUMAN,260 (261),0.593,1,,
Antigen processing: Ubiquitination & Proteasome degradation,Reactome,1,HECD2_HUMAN,261 (264),0.595,1,,
Metabolism of carbohydrates,Reactome,1,DEOC_HUMAN,263 (264),0.597,1,,
miR-targeted genes in epithelium - TarBase,Wikipathways,1,ANXA2_HUMAN,267 (333),0.603,1,,
Chromatin organization,Reactome,1,SETD6_HUMAN,271 (272),0.608,1,,
Chromatin modifying enzymes,Reactome,1,SETD6_HUMAN,271 (272),0.608,1,,
RNA Polymerase II Transcription,Reactome,4,ZN75D_HUMAN;SPT5H_HUMAN;NCBP1_HUMAN;ZN710_HUMAN,1223 (1236),0.612,1,,
Signaling by WNT,Reactome,1,GBG3_HUMAN,277 (278),0.617,1,,
Vesicle-mediated transport,Reactome,2,KIF4B_HUMAN;SCAR5_HUMAN,620 (620),0.633,1,,
Translation,Reactome,1,IF2P_HUMAN,299 (310),0.645,1,,
Focal Adhesion-PI3K-Akt-mTOR-signaling pathway,Wikipathways,1,GBG3_HUMAN,302 (302),0.649,1,,
JAK STAT pathway and regulation,INOH,1,IRAK2_HUMAN,310 (310),0.658,1,,
Nuclear Receptors Meta-Pathway,Wikipathways,1,PTGR1_HUMAN,315 (316),0.664,1,,
Metabolism of lipids,Reactome,2,PTGR1_HUMAN;HMCS2_HUMAN,660 (664),0.667,1,,
Class I MHC mediated antigen processing & presentation,Reactome,1,HECD2_HUMAN,321 (324),0.671,1,,
Metabolism of amino acids and derivatives,Reactome,1,CRNS1_HUMAN,330 (342),0.682,1,,
Class A/1 (Rhodopsin-like receptors),Reactome,1,ADA1D_HUMAN,330 (330),0.682,1,,
Human papillomavirus infection - Homo sapiens (human),KEGG,1,VPP4_HUMAN,339 (339),0.692,1,,
PI3K-Akt Signaling Pathway,Wikipathways,1,GBG3_HUMAN,339 (340),0.692,1,,
Gene expression (Transcription),Reactome,4,ZN75D_HUMAN;SPT5H_HUMAN;NCBP1_HUMAN;ZN710_HUMAN,1360 (1373),0.697,1,,
Signal Transduction,Reactome,8,GBG3_HUMAN;PCSK5_HUMAN;PEBP1_HUMAN;NCBP1_HUMAN;ADA1D_HUMAN;SNAI1_HUMAN;VPP4_HUMAN;STRA6_HUMAN,2634 (2647),0.704,1,,
PI3K-Akt signaling pathway - Homo sapiens (human),KEGG,1,GBG3_HUMAN,353 (354),0.706,1,,
Transcriptional Regulation by TP53,Reactome,1,SPT5H_HUMAN,372 (374),0.725,1,,
Generic Transcription Pathway,Reactome,3,ZN75D_HUMAN;SPT5H_HUMAN;ZN710_HUMAN,1101 (1107),0.739,1,,
miR-targeted genes in lymphocytes - TarBase,Wikipathways,1,ANXA2_HUMAN,409 (489),0.759,1,,
Immune System,Reactome,5,IRAK2_HUMAN;VPP4_HUMAN;HECD2_HUMAN;ANXA2_HUMAN;DEOC_HUMAN,1825 (1840),0.767,1,,
GPCR downstream signalling,Reactome,3,GBG3_HUMAN;ADA1D_HUMAN;STRA6_HUMAN,1172 (1176),0.777,1,,
Cytokine Signaling in Immune system,Reactome,1,IRAK2_HUMAN,458 (458),0.797,1,,
Signaling by GPCR,Reactome,3,GBG3_HUMAN;ADA1D_HUMAN;STRA6_HUMAN,1235 (1240),0.808,1,,
Pathways in cancer - Homo sapiens (human),KEGG,1,GBG3_HUMAN,525 (526),0.84,1,,
G alpha (s) signalling events,Reactome,1,GBG3_HUMAN,581 (583),0.869,1,,
Membrane Trafficking,Reactome,1,KIF4B_HUMAN,582 (582),0.87,1,,
Adaptive Immune System,Reactome,1,HECD2_HUMAN,722 (732),0.922,1,,
Metabolism of proteins,Reactome,3,GBG3_HUMAN;IF2P_HUMAN;ANT3_HUMAN,1991 (2008),0.975,1,,
Post-translational protein modification,Reactome,1,ANT3_HUMAN,1377 (1383),0.993,1,,